Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $504.22)
- $504.22 P/E (TTM): 67.05X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $469.90)
- $469.90 P/E (TTM): 33.26X Cap: $119.22B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 168.27X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.1X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.32X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $172.43)
- $172.43 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $670.46)
- $670.46 P/E (TTM): 53.66X Cap: $53.53B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $100.07)
- $100.07 P/E (TTM): 17.11X Cap: $19.64B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.99)
- $28.99 P/E (TTM): 367.68X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 168.27X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.1X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $14.63)
- $14.63 P/E (TTM): 15.56X Cap: $371M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $22.72)
- $22.72 Cap: $1.57B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX
Elevance Health Inc. (ELV $345.74)
- $345.74 P/E (TTM): 14.15X Cap: $76.83B
- View ELV Profile
- View Questions on ELV

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025